Comparison of anti-inflammatory effects and high-density lipoprotein cholesterol levels between therapy with quadruple-dose rosuvastatin and rosuvastatin combined with ezetimibe

BACKGROUND: Statins are frequently administered to reduce low-density lipoprotein cholesterol (LDL-C) and vascular inflammation, because LDL-C and high sensitive C-reactive protein (hs-CRP) are associated with high risk for cardiovascular events. When statins do not reduce LDL-C to desired levels in...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamazaki, Daisuke, Ishida, Masaru, Watanabe, Hiroyuki, Nobori, Kiyoshi, Oguma, Yasunori, Terata, Yutaka, Koyama, Takashi, Iino, Kenji, Kosaka, Toshimitsu, Ito, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3598241/
https://www.ncbi.nlm.nih.gov/pubmed/23374898
http://dx.doi.org/10.1186/1476-511X-12-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3598241/
https://www.ncbi.nlm.nih.gov/pubmed/23374898
http://dx.doi.org/10.1186/1476-511X-12-9

Ejemplares similares